New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - warfarin sodium 1mg - tablet - 1 mg - active: warfarin sodium 1mg excipient: amaranth lactose magnesium stearate maize starch quinoline yellow stearic acid - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, thromboembolism associated with atrial fibrillation, and as an adjunct in the prophylaxis of systemic embolism after myocardial infarction.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - warfarin sodium 2mg - tablet - 2 mg - active: warfarin sodium 2mg excipient: amaranth indigo carmine lactose magnesium stearate maize starch stearic acid - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, thromboembolism associated with atrial fibrillation, and as an adjunct in the prophylaxis of systemic embolism after myocardial infarction.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - warfarin sodium 5mg - tablet - 5 mg - active: warfarin sodium 5mg excipient: brilliant blue fcf lactose magnesium stearate maize starch quinoline yellow stearic acid - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, thromboembolism associated with atrial fibrillation, and as an adjunct in the prophylaxis of systemic embolism after myocardial infarction.

New Zealand - English - Medsafe (Medicines Safety Authority)

a. menarini new zealand pty ltd - rosuvastatin calcium 10.4mg equivalent to rosuvastatin 10mg;   - film coated tablet - 10 mg - active: rosuvastatin calcium 10.4mg equivalent to rosuvastatin 10mg   excipient: calcium phosphate crospovidone hypromellose iron oxide red lactose monohydrate   magnesium stearate microcrystalline cellulose purified water titanium dioxide triacetin - crestor should be used as an adjunct to diet when the response to diet and exercise is inadequate. prevention of major cardiovascular events in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease, (see clinical efficacy) crestor is indicated to: reduce the risk of nonfatal myocardial infarction reduce the risk of nonfatal stroke reduce the risk of coronary artery revascularisation

New Zealand - English - Medsafe (Medicines Safety Authority)

a. menarini new zealand pty ltd - rosuvastatin calcium 20.8mg equivalent to rosuvastatin 20mg;   - film coated tablet - 20 mg - active: rosuvastatin calcium 20.8mg equivalent to rosuvastatin 20mg   excipient: calcium phosphate crospovidone hypromellose iron oxide red lactose monohydrate   magnesium stearate microcrystalline cellulose purified water titanium dioxide triacetin - crestor should be used as an adjunct to diet when the response to diet and exercise is inadequate. prevention of major cardiovascular events in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease, (see clinical efficacy) crestor is indicated to: reduce the risk of nonfatal myocardial infarction reduce the risk of nonfatal stroke reduce the risk of coronary artery revascularisation

New Zealand - English - Medsafe (Medicines Safety Authority)

a. menarini new zealand pty ltd - rosuvastatin calcium 41.6mg equivalent to rosuvastatin 40mg;   - film coated tablet - 40 mg - active: rosuvastatin calcium 41.6mg equivalent to rosuvastatin 40mg   excipient: calcium phosphate crospovidone hypromellose iron oxide red lactose monohydrate   magnesium stearate microcrystalline cellulose purified water titanium dioxide triacetin - crestor should be used as an adjunct to diet when the response to diet and exercise is inadequate. prevention of major cardiovascular events in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease, (see clinical efficacy) crestor is indicated to: reduce the risk of nonfatal myocardial infarction reduce the risk of nonfatal stroke reduce the risk of coronary artery revascularisation

New Zealand - English - Medsafe (Medicines Safety Authority)

a. menarini new zealand pty ltd - rosuvastatin calcium 5.2mg equivalent to rosuvastatin 5mg;   - film coated tablet - 5 mg - active: rosuvastatin calcium 5.2mg equivalent to rosuvastatin 5mg   excipient: calcium phosphate crospovidone hypromellose iron oxide yellow lactose monohydrate   magnesium stearate microcrystalline cellulose titanium dioxide triacetin - crestor should be used as an adjunct to diet when the response to diet and exercise is inadequate. prevention of major cardiovascular events in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease, (see clinical efficacy) crestor is indicated to: reduce the risk of nonfatal myocardial infarction reduce the risk of nonfatal stroke reduce the risk of coronary artery revascularisation

New Zealand - English - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - midazolam maleate 20.8mg equivalent to 15 mg midazolam - tablet - 15 mg - active: midazolam maleate 20.8mg equivalent to 15 mg midazolam excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose

New Zealand - English - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - midazolam maleate 10.2mg equivalent to 7.5 mg midazolam;   - tablet - 7.5 mg - active: midazolam maleate 10.2mg equivalent to 7.5 mg midazolam   excipient: hypromellose lactose magnesium stearate microcrystalline cellulose purified talc starch titanium dioxide - short-term treatment of insomnia. benzodiazepines are only indicated when the disorder is severe, disabling or subjecting the individual to extreme distress.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - warfarin sodium 1mg - tablet - 1 mg - active: warfarin sodium 1mg excipient: indigo carmine iron oxide red iron oxide yellow lactose monohydrate magnesium stearate maize starch pregelatinised maize starch sodium starch glycolate - coronary occlusion; deep vein thrombosis; pulmonary embolism; peripheral vascular thromboembolic states.